An observational study in Moderate Traumatic Brain Injury, sponsored by Tang-Du Hospital. Recruiting at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-06.
Sponsored by Tang-Du Hospital · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 60 studies in Brain Injuries, Traumatic with a site in China — 29 open to participants now, 30 under way, none of them phase 3. Brain Injuries, Traumatic · China.
Among the 60 studies in Brain Injuries, Traumatic with a site in China, this one is the 2nd largest by planned enrollment of the 34 observational ones that give a count, is one of 4 that started in 2021, is one of 34 observational ones, reaches primary completion later than 16 of the 29 other live ones, and was the 20th registered.
1,725 studies on the registry are indexed under Brain Injuries, Traumatic; 450 are open to participants now.
Browse Brain Injuries, Traumatic studies →29 of the 60 studies in Brain Injuries, Traumatic with a site in China are open now. Recruiting first, the newest first:
Zhangjiagang First People's Hospital · Sites in China
Ages 18–65
Shanghai 6th People's Hospital · Sites in China
Ages 18–80 · Healthy volunteers
Huaqiu Zhang · Sites in China
Ages 18–60
Tang-Du Hospital · Sites in China
Ages 18–75
Shanxi Bethune Hospital · Sites in China
Ages 18–75
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 287 Brain Injuries, Traumatic studies recruiting now, 126 (44%) set no upper age limit and 119 (41%) stop at 75 or younger; 41 take children under 18; 53 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
60 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 3 · Phase 3 1 · Phase 4 3
First in 2006; this study’s year is marked. 4 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 1,000 is above the median of 116 across 558 observational studies indexed under Brain Injuries, Traumatic.
Median enrollment 83 across the 26 interventional studies, 110 across the 34 observational. Of the 11 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 60 has an industry lead sponsor. The 10 most frequent:
Tang-Du Hospital is the lead sponsor of 167 studies on the registry; 78 are open to participants now.
Tang-Du Hospital has 7 studies filed under Brain Injuries, Traumatic — fewer than ten, so there is no comparison to draw.
7 of the studies in Brain Injuries, Traumatic with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07115459Xiangya Hospital of Central South UniversityDevelopment and Validation of a Prognostic Model for Neurocritical Patients Using Multimodal Brain Monitoring | 2026-12-31 |
| NCT06429774Beijing Tiantan HospitalComparative Effectiveness of Intervention in Multi-level Hospitals for Acute Traumatic Brain Injury(Metric-TBI) | 2026-12-31 |
| NCT04900168Tang-Du HospitalIntracranial Pressure Monitoring in Moderate Traumatic Brain Injury | 2026-12-31 |
| NCT06241482Shanghai 6th People's HospitalSafety and Efficacy of Enhanced Recovery After Surgery in Neurocritical Care | 2027-04-30 |
| NCT06909071Shanxi Bethune HospitalHybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT | 2027-06-30 |
Add all 7 to your calendar (.ics) → With an account.
Among the 60 studies in Brain Injuries, Traumatic with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Objectives The primary focus for scientific investigation is to conduct a multi-center observational study to determine if intracranial pressure (ICP) monitoring to direct treatment of patients with moderate traumatic brain injury (TBI) improves medical practice and patient outcomes in China.
Design and Outcomes This is a prospective observational cohort multi-center study with blinded evaluation of outcome. Neurologic outcome is evaluated by extended Glasgow outcome score(GOSE) at 6 months.
Interventions and Duration This is an observational study. The decision of intracranial pressure monitoring is made by the relatives of patient. Management of all patients will be consistent with protocols presently being used in the study hospitals. For patients who received ICP monitoring, the management will also be based specifically on the presence of intracranial hypertension.
Sample Size and Population Sample size calculation: Not applicable. The sample size will be equal to the total number of moderate trumatic brain injury patients consecutively admitted to hospitals during the study period.
The criteria were revised on the registry on Nov 6, 2026. See what changed
Adult patient with acute moderate traumatic brain injury
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Good neurologic outcome
The proportion of patients with good neurological outcomes (GOSE: 5-8) in each group at 6 months after traumatic brain injury
Time frame: Within 6 months after traumatic brain injury
6 months mortality
The mortality of patients in each group at 6 months after traumatic brain injury
Time frame: Within 6 months after traumatic brain injury
In-hospital mortality
The mortality of patients in each group during hospitalization
Time frame: Within 1 month after traumatic brain injury
Plan to share: Undecided
Started Jun 2021 (actual). Primary completion is estimated for Dec 2026, 66 months after the start.
Of 231 non-industry observational studies under Brain Injuries, Traumatic, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 95. This study's planned 66 months is above that.
Counting every sponsor, half of 253 studies reached it within 49 months; a quarter within 23 and three quarters within 95.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 6, 2026: primary completion Dec 2023 → Dec 2026 and completion Jun 2024 → Jun 2027.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.